{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:53:11Z","timestamp":1773903191176,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.neuropharm.2008.08.033","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T19:14:09Z","timestamp":1221160449000},"page":"1340-1346","source":"Crossref","is-referenced-by-count":59,"title":["Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism"],"prefix":"10.1016","volume":"55","author":[{"given":"Amany A.","family":"Abdin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala E.","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2008.08.033_bib1","series-title":"Methods of Enzymatic Analysis","first-page":"539","article-title":"Adenosine 5-triphosphate determination with phosphoglycerate kinase","author":"Adams","year":"1963"},{"issue":"1","key":"10.1016\/j.neuropharm.2008.08.033_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0166-4328(02)00180-8","article-title":"Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats","volume":"136","author":"Alam","year":"2002","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2008.08.033_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbr.2003.12.021","article-title":"L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats","volume":"153","author":"Alam","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib4","first-page":"25","article-title":"Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease","volume":"12","author":"Anglade","year":"1997","journal-title":"Histol. Histopathol."},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2008.08.033_bib5","doi-asserted-by":"crossref","first-page":"s169","DOI":"10.1016\/S0098-2997(97)00024-1","article-title":"Coenzyme Ql0 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases","volume":"18","author":"Beal","year":"1997","journal-title":"Mol. Aspects Med."},{"issue":"12","key":"10.1016\/j.neuropharm.2008.08.033_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2008.08.033_bib7","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.mito.2007.03.003","article-title":"Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations","volume":"7","author":"Bhagavan","year":"2007","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.neuropharm.2008.08.033_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/bmmb.1994.1004","article-title":"An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria","volume":"51","author":"Birch-Machin","year":"1994","journal-title":"Biochem. Med. Metab. Biol."},{"issue":"8","key":"10.1016\/j.neuropharm.2008.08.033_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00702-004-0123-1","article-title":"Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson's disease. The effect of dopaminergic treatment","volume":"111","author":"Blandini","year":"2004","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib10","first-page":"1065","article-title":"Coenzyme Q10","volume":"72","author":"Bonakdar","year":"2005","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.neuropharm.2008.08.033_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/385434a0","article-title":"Bcl-2 promotes regeneration of severed axons in mammalian CNS","volume":"385","author":"Chen","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2008.08.033_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0026-265X(78)90034-6","article-title":"Further modification of a fluorometric method for analyzing brain amines","volume":"23","author":"Ciarolone","year":"1978","journal-title":"Microchem. J."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib13","first-page":"1045","article-title":"Parkinson's disease","volume":"75","author":"Clarke","year":"2007","journal-title":"Am. Fam. Physician"},{"issue":"6","key":"10.1016\/j.neuropharm.2008.08.033_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/07315724.2001.10719063","article-title":"Biochemical functions of coenzyme Q10","volume":"20","author":"Crane","year":"2001","journal-title":"J. Am. Coll. Nutr."},{"issue":"6812","key":"10.1016\/j.neuropharm.2008.08.033_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/35046114","article-title":"Coenzyme Q is an obligatory cofactor for uncoupling protein function","volume":"408","author":"Echtay","year":"2000","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.neuropharm.2008.08.033_bib16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1073\/pnas.0605208103","article-title":"Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.neuropharm.2008.08.033_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-4165(02)00440-3","article-title":"Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells","volume":"1619","author":"Emdadul Haque","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2008.08.033_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1749-6632.2003.tb07469.x","article-title":"Mitochondrial mechanisms of neural cell death and neuroprotective interventions in parkinson's disease","volume":"991","author":"Fiskum","year":"2003","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2008.08.033_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0092-8674(93)80066-N","article-title":"Bcl-2 functions in an antioxidant pathway to prevent apoptosis","volume":"75","author":"Hockenbery","year":"1993","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neuropharm.2008.08.033_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2131\/jts.32.437","article-title":"Thirteen-week repeated dose oral toxicity study of coenzyme Q10 in rats","volume":"32","author":"Honda","year":"2007","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib21","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1093\/jn\/130.9.2343","article-title":"Dietary coenzyme Q10 and vitamin E alter the status of these compounds in rat tissues and mitochondria","volume":"130","author":"Ibrahim","year":"2000","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.neuropharm.2008.08.033_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s007020050001","article-title":"Cell death mechanisms in Parkinson's disease","volume":"107","author":"Jellinger","year":"2000","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.neuropharm.2008.08.033_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s007020050015","article-title":"Serum levels of coenzyme Q10 in patients with Parkinson's disease","volume":"107","author":"Jimenez-Jimenez","year":"2000","journal-title":"J. Neural Transm."},{"issue":"8","key":"10.1016\/j.neuropharm.2008.08.033_bib23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0731-7085(98)00003-X","article-title":"Application of derivative spectrophotometry for determination of coenzyme Q10 in pharmaceuticals and plasma","volume":"17","author":"Karpi\u0144ska","year":"1998","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.neuropharm.2008.08.033_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1248\/bpb.25.284","article-title":"Antiparkinsonian drugs and their neuroprotective effects","volume":"25","author":"Kitamura","year":"2002","journal-title":"Biol. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.neuropharm.2008.08.033_bib25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1385\/JMN:28:2:125","article-title":"Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons","volume":"28","author":"Kooncumchoo","year":"2006","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s004010050590","article-title":"On the question of apoptosis in the parkinsonian substantia nigra","volume":"93","author":"Kosel","year":"1997","journal-title":"Acta Neuropathol. (Berl.)"},{"issue":"11","key":"10.1016\/j.neuropharm.2008.08.033_bib27","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.freeradbiomed.2004.09.005","article-title":"Bcl-2 family proteins regulate mitochondrial reactive oxygen production and protect against oxidative stress","volume":"37","author":"Kowaltowski","year":"2004","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.neuropharm.2008.08.033_bib28","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0891-5849(02)00916-4","article-title":"Effects of coenzyme Q10 administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat","volume":"33","author":"Kwong","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin-Phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.neuropharm.2008.08.033_bib30","doi-asserted-by":"crossref","first-page":"8892","DOI":"10.1073\/pnas.95.15.8892","article-title":"Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects","volume":"95","author":"Matthews","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.neuropharm.2008.08.033_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(03)00185-X","article-title":"Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease","volume":"341","author":"M\u00fcller","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archneur.63.5.649","article-title":"Mitochondria in Parkinson disease: back in fashion with a little help from genetics","volume":"63","author":"Muqit","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib33","doi-asserted-by":"crossref","first-page":"9893","DOI":"10.1073\/pnas.93.18.9893","article-title":"Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria","volume":"93","author":"Murphy","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.neuropharm.2008.08.033_bib34","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s10495-006-8417-4","article-title":"Water-soluble formulation of Coenzyme Q10 inhibits Bax-induced destabilization of mitochondria in mammalian cells","volume":"11","author":"Naderi","year":"2006","journal-title":"Apoptosis"},{"issue":"8","key":"10.1016\/j.neuropharm.2008.08.033_bib35","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.bjp.0704982","article-title":"Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by l-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine","volume":"137","author":"Pedrosa","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.neuropharm.2008.08.033_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.cr.7290235","article-title":"Biomarkers of neurodegenerative disorders: how good are they?","volume":"14","author":"Rachakonda","year":"2004","journal-title":"Cell Res."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib37","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","article-title":"Diagnosis and treatment of parkinson disease: molecules to medicine","volume":"116","author":"Savitt","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.neuropharm.2008.08.033_bib38","first-page":"95","article-title":"Plasma and tissue concentrations of coenzyme Q10 in the rat after its oral administration","volume":"10","author":"Scalori","year":"1988","journal-title":"Int. J. Tissue React."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib39","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.291.3.358","article-title":"Neuroprotection in parkinson disease. Mysteries, myths, and misconceptions","volume":"291","author":"Schapira","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2008.08.033_bib40","first-page":"273","article-title":"Controversies on new animal models of Parkinson's disease pro and con: the rotenone model of Parkinson's disease (PD)","volume":"70","author":"Schmidt","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0005-2728(01)00183-9","article-title":"Functional coupling of PSST and ND1 subunits in NADH:ubiquinone oxidoreductase established by photoaffinity labeling","volume":"1506","author":"Schuler","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.neuropharm.2008.08.033_bib42","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0891-5849(03)00103-5","article-title":"Gene dosage-dependent effects of bcl-2 expression on cellular survival and redox status","volume":"34","author":"Seyfried","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib43","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002","article-title":"An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered-synuclein metabolism and oxidative damage","volume":"22","author":"Sherer","year":"2002","journal-title":"J. Neurosci."},{"issue":"34","key":"10.1016\/j.neuropharm.2008.08.033_bib44","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson's disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2008.08.033_bib46","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline","volume":"59","author":"Shults","year":"2002","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.neuropharm.2008.08.033_bib45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.expneurol.2004.05.003","article-title":"Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease","volume":"188","author":"Shults","year":"2004","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.neuropharm.2008.08.033_bib47","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archneur.64.7.nct60005","article-title":"Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q10 in parkinson disease","volume":"64","author":"Storch","year":"2007","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.neuropharm.2008.08.033_bib48","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1084\/jem.184.4.1331","article-title":"Bcl-2 inhibits the mitochondrial release of an apoptogenic protease","volume":"184","author":"Susin","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib49","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1046\/j.1471-4159.2000.0752611.x","article-title":"In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone","volume":"75","author":"Talpade","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib50","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/BF00970754","article-title":"Changes of mitochondrial membrane proteins in rat cerebellum during aging","volume":"13","author":"Turpeenoja","year":"1988","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib51","first-page":"2113","article-title":"Blood concentration of coenzyme Q10 increases in rats when esterified forms are administered","volume":"129","author":"Turunen","year":"1999","journal-title":"J. Nutr."},{"issue":"9\u201310","key":"10.1016\/j.neuropharm.2008.08.033_bib52","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0891-5849(99)00174-4","article-title":"BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity","volume":"27","author":"Voehringer","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.neuropharm.2008.08.033_bib53","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1359-6446(03)03000-9","article-title":"Interrupting apoptosis in neurodegenerative disease: potential for effective therapy?","volume":"9","author":"Waldmeier","year":"2004","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.neuropharm.2008.08.033_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0306-4522(02)00210-5","article-title":"Changes in cortical and cerebellar bcl-2 mRNA levels in the developing hydrocephalic rat (LEW-HYR) as measured by a real time quantified RT-PCR","volume":"114","author":"Yamada","year":"2002","journal-title":"Neuroscience"},{"issue":"5303","key":"10.1016\/j.neuropharm.2008.08.033_bib55","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.275.5303.1129","article-title":"Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked","volume":"275","author":"Yang","year":"1997","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.neuropharm.2008.08.033_bib56","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.1523\/JNEUROSCI.18-20-08145.1998","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2","volume":"18","author":"Yang","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2008.08.033_bib57","first-page":"195","article-title":"Modulation of control mechanisms of dopamine-induced apoptosis\u2013a future approach to the treatment of Parkinson's disease?","volume":"49","author":"Ziv","year":"1997","journal-title":"J. Neural Transm. Suppl."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808003821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390808003821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T08:46:31Z","timestamp":1631781991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390808003821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0028390808003821"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2008.08.033","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}